This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Europe

  1. This week, as world leaders gather in Geneva for the World Health Assembly, universal health coverage—a goal the world has set to achieve by 2030—will be a major focus. PATH advocate Brian Atuhaire shares why moments like this are more than just milestones.
    Published: May 2019
    Type: Article
  2. PATH's statement on the floor of the 72nd World Health Assembly in Geneva, Switzerland, calling on WHO to work with member states to ensure that they meet their budget targets on funding for health, because without sustainable domestic financing on health the world will never achieve UHC. To truly achieve UHC—and realize its health, economic, and social benefits—we must advance a UHC agenda that recognizes and prioritizes SRHR and delivers lifesaving and critical services to all people require them.
    Published: May 2019
    Type: Resource Page
  3. PATH's statement on the floor of the 72nd World Health Assembly in Geneva, Switzerland, affirming the belief that primary health care (PHC) is the most efficient and cost-effective way to achieve our shared goals of universal health coverage (UHC) as outlined in the SDGs. PATH emphasizes the importance of civic engagement and new innovations in health to achieve UHC and PHC through the transformative power of digital technologies.
    Published: May 2019
    Type: Resource Page
  4. PATH's statement on the floor of the 72nd World Health Assembly in Geneva, Switzerland, supporting a holistic and streamlined approach to overcoming barriers to access to medicines and vaccines.
    Published: May 2019
    Type: Resource Page
  5. As decisions are being made about the future of partnerships under Horizon Europe, PATH and other Product Development Partnership (PDP) organizations call on the EU to once again include an ambitious partnership exclusively dedicated to funding research for the prevention and treatment of poverty-related and neglected diseases. In this position paper, PATH and partners specifically encourage enhanced partnership opportunities to bolster collaboration and leverage funding from partners, including PDPs and the private and philanthropic sectors, a more flexible portfolio approach to funding, and an ambitious doubling of the program to 1.36 billion Euros from the European Commission.
    Published: April 2019
    Type: Resource Page
  6. This report outlines achievements from investment and incentives in health innovation and how the G20 and associated multilaterals are essential to addressing the pressing global health challenges of our time. It also highlights existing and new models for innovative and blended forms of financing that significantly supplement funds that are currently provided by the governments, the private sector and philanthropic organizations.
    Published: March 2019
    Type: Resource Page
  7. PATH delivers a statement at the 144th World Health Organization Executive Board meetings encouraging a focus on strong, harmonized regulatory systems for research and development of the medicines and vaccines that help solve global health challenges.
    Published: January 2019
    Type: Resource Page
  8. This year's annual report features our annual financial overview, PATH’s leadership, list of PATH’s funders and supporters, and our vision for PATH's future.
    Published: December 2018
    Type: Resource Page
  9. As a nine-year project to build vaccine development capacity worldwide comes to an end, PATH and partners reflect on how far we’ve come.
    Published: September 2018
    Type: Article
  10. Vietnam has been working for nearly a decade to develop and manufacture influenza vaccines. With PATH support, the Institute of Vaccines and Medical Biologicals has done just that—and it has submitted two candidates for licensure.
    Published: September 2018
    Type: Article
Load more